1. Home
  2. MTDR vs JAZZ Comparison

MTDR vs JAZZ Comparison

Compare MTDR & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MTDR

Matador Resources Company

HOLD

Current Price

$41.94

Market Cap

5.4B

Sector

Energy

ML Signal

HOLD

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$169.44

Market Cap

10.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTDR
JAZZ
Founded
2003
2003
Country
United States
Ireland
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
10.8B
IPO Year
2012
2007

Fundamental Metrics

Financial Performance
Metric
MTDR
JAZZ
Price
$41.94
$169.44
Analyst Decision
Buy
Strong Buy
Analyst Count
16
15
Target Price
$62.60
$199.20
AVG Volume (30 Days)
1.4M
1.1M
Earning Date
10-21-2025
11-05-2025
Dividend Yield
3.58%
N/A
EPS Growth
N/A
N/A
EPS
6.24
N/A
Revenue
$3,556,751,000.00
$4,157,832,999.00
Revenue This Year
$14.79
$6.00
Revenue Next Year
$1.05
$6.47
P/E Ratio
$6.72
N/A
Revenue Growth
14.75
4.14
52 Week Low
$35.19
$95.49
52 Week High
$64.05
$182.99

Technical Indicators

Market Signals
Indicator
MTDR
JAZZ
Relative Strength Index (RSI) 47.12 58.20
Support Level $40.70 $164.39
Resistance Level $42.73 $171.47
Average True Range (ATR) 1.31 4.17
MACD -0.35 -1.06
Stochastic Oscillator 21.72 76.36

Price Performance

Historical Comparison
MTDR
JAZZ

About MTDR Matador Resources Company

Matador Resources Co is an independent energy company engaged in the exploration, development, production, and acquisition of oil and natural gas resources. The majority of the company's assets are located in the United States, with an emphasis on oil and natural gas shale and other unconventional plays. Along with maintaining a portfolio of oil and natural gas properties, Matador works to identify and develop midstream opportunities that support and enhance its exploration and development business. The Company has two reportable business segments: exploration and production and midstream.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: